A. Berns

2.4k total citations
18 papers, 1.9k citations indexed

About

A. Berns is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, A. Berns has authored 18 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 4 papers in Neurology. Recurrent topics in A. Berns's work include Cancer Mechanisms and Therapy (5 papers), Sarcoma Diagnosis and Treatment (3 papers) and Peptidase Inhibition and Analysis (3 papers). A. Berns is often cited by papers focused on Cancer Mechanisms and Therapy (5 papers), Sarcoma Diagnosis and Treatment (3 papers) and Peptidase Inhibition and Analysis (3 papers). A. Berns collaborates with scholars based in Netherlands, United States and France. A. Berns's co-authors include Jos Jonkers, Marco Giovannini, Martin van der Valk, John G. Collard, Gaston Habets, Jord C. Stam, Rob A. van der Kammen, Paul Krimpenfort, James M. Woodruff and Laurence Goutebroze and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

A. Berns

17 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Berns Netherlands 14 1.1k 453 392 348 303 18 1.9k
Virginia Bertness United States 16 1.1k 1.1× 460 1.0× 355 0.9× 194 0.6× 278 0.9× 18 1.9k
A. Thomas Look United States 27 1.2k 1.1× 596 1.3× 322 0.8× 126 0.4× 242 0.8× 40 2.3k
Marc Lipinski France 28 1.8k 1.7× 306 0.7× 413 1.1× 165 0.5× 269 0.9× 67 2.6k
Leah Conroy United States 12 1.5k 1.4× 291 0.6× 214 0.5× 521 1.5× 135 0.4× 13 2.3k
Daniel Gallahan United States 20 2.1k 2.0× 572 1.3× 302 0.8× 251 0.7× 435 1.4× 30 2.7k
Françoise Moreau-Gachelin France 27 2.0k 1.9× 521 1.2× 958 2.4× 199 0.6× 398 1.3× 70 3.2k
Ignacio Moreno de Alborán Spain 19 1.4k 1.4× 656 1.4× 604 1.5× 241 0.7× 211 0.7× 31 2.2k
Rossano Cesari United States 20 1.1k 1.1× 664 1.5× 443 1.1× 85 0.2× 356 1.2× 34 2.1k
Maurits F. Kleijnen United States 8 754 0.7× 467 1.0× 208 0.5× 298 0.9× 106 0.3× 9 1.2k
Elizabeth E. Reczek United States 9 2.1k 2.0× 1.2k 2.6× 305 0.8× 253 0.7× 197 0.7× 10 3.2k

Countries citing papers authored by A. Berns

Since Specialization
Citations

This map shows the geographic impact of A. Berns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Berns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Berns more than expected).

Fields of papers citing papers by A. Berns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Berns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Berns. The network helps show where A. Berns may publish in the future.

Co-authorship network of co-authors of A. Berns

This figure shows the co-authorship network connecting the top 25 collaborators of A. Berns. A scholar is included among the top collaborators of A. Berns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Berns. A. Berns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Badhai, Jitendra, Rajith Bhaskaran, Ji‐Ying Song, et al.. (2018). PO-223 Modelling malignant mesothelioma in mice: a critical role for BAP1 loss. ESMO Open. 3. A314–A315. 1 indexed citations
2.
Semenova, Ekaterina A., Franziska Böttger, Ji‐Ying Song, et al.. (2018). PO-338 Tumour heterogeneity underlies differential cisplatin sensitivity in mouse models of SCLC. ESMO Open. 3. A360–A361. 1 indexed citations
3.
Maclellan, Reid A., Marc Vooijs, Peter Frenkel, et al.. (2002). Cardiac-restricted targeting of the retinoblastoma gene reveals a role for Rb in terminal cardiac differentiation and apoptosis. 3155. 1 indexed citations
4.
Giovannini, Marco, Els C. Robanus-Maandag, Michiko Niwa‐Kawakita, et al.. (2000). Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.. HAL (Le Centre pour la Communication Scientifique Directe). 13 indexed citations
5.
Giovannini, Marco, Els C. Robanus-Maandag, Martin van der Valk, et al.. (2000). Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes & Development. 14(13). 1617–1630. 297 indexed citations
6.
Giovannini, Marco, Els C. Robanus-Maandag, Michiko Niwa‐Kawakita, et al.. (1999). Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein. Genes & Development. 13(8). 978–986. 105 indexed citations
7.
Allen, John, Els Verhoeven, Jos Domen, Martin van der Valk, & A. Berns. (1997). Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc. Oncogene. 15(10). 1133–1141. 135 indexed citations
8.
Akagi, Keiko, Marc Vooijs, Marco Giovannini, et al.. (1997). Cre-mediated somatic site-specific recombination in mice. Nucleic Acids Research. 25(9). 1766–1773. 204 indexed citations
9.
Schwarz, Edward M., Paul Krimpenfort, A. Berns, & Inder M. Verma. (1997). Immunological defects in mice with a targeted disruption in Bcl-3.. Genes & Development. 11(2). 187–197. 139 indexed citations
10.
Allen, John & A. Berns. (1996). Complementation tagging of cooperating oncogenes in knockout mice. Seminars in Cancer Biology. 7(5). 299–306. 36 indexed citations
11.
Jonkers, Jos & A. Berns. (1996). Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1287(1). 29–57. 157 indexed citations
12.
Dwarki, Varavani, Paula Belloni, Tarlochan Nijjar, et al.. (1995). Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice.. Proceedings of the National Academy of Sciences. 92(4). 1023–1027. 94 indexed citations
13.
Renauld, Jean‐Christophe, Anne Vink, Catherine Godfraind, et al.. (1994). Thymic lymphomas in interleukin 9 transgenic mice.. PubMed. 9(5). 1327–32. 124 indexed citations
15.
Domen, Jos, et al.. (1993). Pim-1 levels determine the size of early B lymphoid compartments in bone marrow.. The Journal of Experimental Medicine. 178(5). 1665–1673. 67 indexed citations
16.
Berns, A.. (1991). Tumorigenesis in transgenic mice: Identification and characterization of synergizing oncogenes. Journal of Cellular Biochemistry. 47(2). 130–135. 40 indexed citations
17.
Kievits, Femia, P. Iványi, Paul Krimpenfort, A. Berns, & Hidde L. Ploegh. (1987). HLA-restricted recognition of viral antigens in HLA transgenic mice. Nature. 329(6138). 447–449. 71 indexed citations
18.
Berns, A., et al.. (1972). Hazard of Combining Allopurinol and Thiopurine. New England Journal of Medicine. 286(13). 730–731. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026